Name: Latest research reports of Cipla Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 3
Author: Motilal Oswal

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1575.8000 -2.40 (-0.15%)

NSE Sep 19, 2025 15:58 PM

Volume: 1.5M

Cipla Ltd.

06 Aug 2021

1575.80

-0.15%

Adding peptide injectables to Respiratory pipeline for US market

Neutral: Cipla Ltd.

Target

Motilal Oswal

Adding peptide injectables to Respiratory pipeline for US market Motilal Oswal values your support in the Asiamoney Brokers Poll 2021...

Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.